Skip to content
AdminJan 18, 2023< 1 min read

Generating and Evaluating Synthetic Clinical Trial Data in a Pharmaceutical Company


Mark Baillie & Lucy Mosquera

In this webinar, Mark Baillie from Novartis discusses a project to generate synthetic clinical trial datasets and use cases for synthetic clinical trial. Replica’s Lucy Mosquera shares how the datasets for the project were synthesized and results of privacy and utility assessments on the synthetic datasets.



Following the acquisition of Replica Analytics by Aetion, the generative AI technology previously known as Replica Synthesis is now Aetion® Generate and continues to create privacy-enhancing synthetic data.